Clinical, immunological and genetic features in Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES)

Immunobiology

Volumn 216, Issue 8, 2011, Pages 909-917

  Lee, Wen I ^a   Huang, Jing Long ^a   Lin, Syh Jae ^a   Yeh, Kuo Wei ^a   Chen, Li Chen ^a   Ou, Liang Shiou ^a   Yao, Tsung Chieh ^a   Hsieh, Meng Ying ^a   Huang, Yhu Chering ^a   Yu, Hong Ren ^a   Kuo, Ho Chang ^a   Yang, Kunder D ^a   Jaing, Tang Her ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chinese; DOCK8; Hyper IgE recurrent infection syndromes (HIES); Primary immunodeficiency diseases (PIDs); STAT3; Taiwan; TYK2

Indexed keywords

CELL PROTEIN; DEDICATOR OF CYTOKINESIS 8; IMMUNOGLOBULIN; LEAD; PROTEIN KINASE TYK2; RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AMENORRHEA; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN VASCULITIS; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS RETINITIS; EXON; FACIES; FEMALE; FOLLOW UP; GENE DELETION; GENETIC ASSOCIATION; HEART INFARCTION; HUMAN; HUMAN CELL; HYPERIMMUNOGLOBULIN E RECURRENT INFECTION SYNDROME; IMMUNE DEFICIENCY; INFANT; LYMPHOMA; MALE; MEMORY CELL; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PNEUMATOCELE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEUS INFECTION; SCHOOL CHILD; STAPHYLOCOCCAL BACTEREMIA; TAIWAN; TH17 CELL;

ADOLESCENT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOGLOBULIN E; INFANT; INFANT, NEWBORN; JOB'S SYNDROME; LONGITUDINAL STUDIES; MALE; MUTATION; PHENOTYPE; RETINITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; STAT3 TRANSCRIPTION FACTOR; TAIWAN; TYK2 KINASE;

EID: 79959522179     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.01.008     Document Type: Article

References (38)

1. Buckley R.H., Wray B.B., Belmaker E.Z. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 1972, 49:59-70.
2. Davis S.D., Schaller J., Wedgwood R.J. Lancet 1966, 1:1013-1015.
3. Dohil M., Prendiville J.S. Treatment of molluscum contagiosum with oral cimetidine: clinical experience in 13 patients. Pediatr. Dermatol. 1996, 13:310-312.
4. Engelhardt K.R., McGhee S., Winkler S., Sassi A., Woellner C., Lopez-Herrera G., Chen A., Kim H.S., Lloret M.G., Schulze I., Ehl S., Thiel J., Pfeifer D., Veelken H., Niehues T., Siepermann K., Weinspach S., Reisli I., Keles S., Genel F., Kutuculer N., Camcioĝlu Y., Somer A., Karakoc-Aydiner E., Barlan I., Gennery A., Metin A., Degerliyurt A., Pietrogrande M.C., Yeganeh M., Baz Z., Al-Tamemi S., Klein C., Puck J.M., Holland S.M., McCabe E.R., Grimbacher B., Chatila T.A. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J. Allergy Clin. Immunol. 2009, 124:1289-1302.
5. Etzioni A., Shehadeh N., Brecher A., Yorman S., Pollack S. Cyclosporin A in hyperimmunoglobulin E syndrome. Ann. Allergy Asthma Immunol. 1997, 78:413-414.
6. Freeman A.F., Kleiner D.E., Nadiminti H., Davis J., Quezado M., Anderson V., Puck J.M., Holland S.M. Causes of death in hyper-IgE syndrome. J. Allergy Clin. Immunol. 2007, 119:1234-1240.
7. Gatz SA, Benninghoff U, Schütz C, Schulz A, Hönig M, Pannicke U, Holzmann KH, Schwarz K, Friedrich W. 2010. Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant. Jul 12. (Epub ahead of print).
8. Goussetis E., Peristeri I., Kitra V., Traeger-Synodinos J., Theodosaki M., Psarra K., Kanariou M., Tzortzatou-Stathopoulou F., Petrakou E., Fylaktou I., Kanavakis E., Graphakos S. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J. Allergy Clin. Immunol. 2010, 126:392-394.
9. Griggs B.L., Ladd S., Decker A., DuPont B.R., Asamoah A., Srivastava A.K. Identification of ectodysplasin-A receptor gene deletion at 2q12.2 and a potential autosomal MR locus. Eur. J. Hum. Genet. 2009, 17:30-36.
10. Grimbacher B., Holland S.M., Gallin J.I., Greenberg F., Hill S.C., Malech H.L., Miller J.A., O'Connell A.C., Puck J.M. Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystem disorder. N. Engl. J. Med. 1999, 340:692-702.
11. Grimbacher B., Holland S.M., Puck J.M. Hyper-IgE syndromes. Immunol. Rev. 2005, 203:244-250.
12. Grimbacher B., Schäffer A.A., Holland S.M., Davis J., Gallin J.I., Malech H.L., Atkinson T.P., Belohradsky B.H., Buckley R.H., Cossu F., Español T., Garty B.Z., Matamoros N., Myers L.A., Nelson R.P., Ochs H.D., Renner E.D., Wellinghausen N., Puck J.M. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am. J. Hum. Genet. 1999, 65:735-744.
13. Heimall J., Freeman A., Holland S.M. Pathogenesis of hyper IgE syndrome. Clin. Rev. Allergy Immunol. 2010, 38:32-38.
14. Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., Anderson V.L., Darnell D.N., Welch P.A., Kuhns D.B., Frucht D.M., Malech H.L., Gallin J.I., Kobayashi S.D., Whitney A.R., Voyich J.M., Musser J.M., Woellner C., Schäffer A.A., Puck J.M., Grimbacher B. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 2007, 357:1608-1919.
15. Kilic S.S., Kilicbay F. Interferon-alpha treatment of molluscum contagiosum in a patient with hyperimmunoglobulin E syndrome. Pediatrics 2006, 117:e1253-1255.
16. Lee W.I., Jaing T.H., Hsieh M.Y., Kuo M.L., Lin S.J., Huang J.L. Distribution, infections, treatments and molecular analysis in a large cohort of patients with primary immunodeficiency diseases (PIDs) in Taiwan. J. Clin. Immunol. 2006, 26:274-283.
17. Lee W.I., Kuo M.L., Huang J.L., Lin S.J., Wu C.J. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J. Clin. Immunol. 2005, 25:162-173.
18. Lee W.I., Torgerson T.R., Schumacher M.J., Yel L., Zhu Q., Ochs H.D. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 2005, 105:1881-1890.
19. Lee W.I., Zhu Q., Gambineri E., Jin Y., Welcher A.A., Ochs H.D. Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis. J. Allergy Clin. Immunol. 2003, 112:958-964.
20. Levy D.E., Lee C.K. What does Stat3 do?. J. Clin. Invest. 2002, 109:1143-1148.
21. Liang F.C., Wei Y.C., Jiang T.H., Hsiehi M.Y., Wen Y.C., Chiou Y.S., Wu S.H., Chen L.C., Huang J.L., Lee W.I. Current classification and status of primary immunodeficiency diseases in Taiwan. Acta Paediatr. Taiwan 2008, 49:3-8.
22. Liu, J.Y., Li, Q., Chen, T.T., Guo, X., Ge, J., Yuan, L.X. 2010. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S). Eur J. Pediatr. Nov 24. (Epub ahead of print).
23. Minegishi Y., Saito M., Morio T., Watanabe K., Agematsu K., Tsuchiya S., Takada H., Hara T., Kawamura N., Ariga T., Kaneko H., Kondo N., Tsuge I., Yachie A., Sakiyama Y., Iwata T., Bessho F., Ohishi T., Joh K., Imai K., Kogawa K., Shinohara M., Fujieda M., Wakiguchi H., Pasic S., Abinun M., Ochs H.D., Renner E.D., Jansson A., Belohradsky B.H., Metin A., Shimizu N., Mizutani S., Miyawaki T., Nonoyama S., Karasuyama H. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006, 25:745-755.
24. Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., Metin A., Karasuyama H. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007, 448:1058-1062.
25. Miyamoto Y., Yamauchi J., Sanbe A., Tanoue A. Dock6, a Dock-C subfamily guanine nucleotide exchanger, has the dual specificity for Rac1 and Cdc42 and regulates neurite outgrowth. Exp. Cell Res. 2007, 313:791-804.
26. Niu G., Wright K.L., Huang M., Song L., Haura E., Turkson J., Zhang S., Wang T., Sinibaldi D., Coppola D., Heller R., Ellis L.M., Karras J., Bromberg J., Pardoll D., Jove R., Yu H. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002, 21:2000-2008.
27. Notarangelo L.D., Fischer A., Geha R.S., Casanova J.L., Chapel H., Conley M.E., Cunningham-Rundles C., Etzioni A., Hammartröm L., Nonoyama S., Ochs H.D., Puck J., Roifman C., Seger R., Wedgwood J. in International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies Primary immunodeficiencies: 2009 update. J. Allergy Clin. Immunol. 2009, 124:1161-1178.
28. Renner E.D., Puck J.M., Holland S.M., Schmitt M., Weiss M., Frosch M., Bergmann M., Davis J., Belohradsky B.H., Grimbacher B. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J. Pediatr. 2004, 144:93-99.
29. Renner E.D., Torgerson T.R., Rylaarsdam S., Añover-Sombke S., Golob K., LaFlam T., Zhu Q., Ochs H.D. STAT3 mutation in the original patient with Job's syndrome. N. Engl. J. Med. 2007, 357:1667-1668.
30. Renner E.D., Rylaarsdam S., Anover-Sombke S., Rack A.L., Reichenbach J., Carey J.C., Zhu Q., Jansson A.F., Barboza J., Schimke L.F., Leppert M.F., Getz M.M., Seger R.A., Hill H.R., Belohradsky B.H., Torgerson T.R., Ochs H.D. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J. Allergy Clin. Immunol. 2008, 122:181-187.
31. Speckmann C., Enders A., Woellner C., Thiel D., Rensing-Ehl A., Schlesier M., Rohr J., Jakob T., Oswald E., Kopp M.V., Sanal O., Litzman J., Plebani A., Pietrogrande M.C., Franco J.L., Espanol T., Grimbacher B., Ehl S. Reduced memory B cells in patients with hyper IgE syndrome. Clin. Immunol. 2008, 129:448-454.
32. Vinci G., Chantot-Bastaraud S., El Houate B., Lortat-Jacob S., Brauner R., McElreavey K. Association of deletion 9p 46,XY gonadal dysgenesis and autistic spectrum disorder. Mol. Hum. Reprod. 2007, 13:685-689.
33. Woellner C., Gertz E.M., Schäffer A.A., Lagos M., Perro M., Glocker E.O., Pietrogrande M.C., Cossu F., Franco J.L., Matamoros N., Pietrucha B., Heropolitańska-Pliszka E., Yeganeh M., Moin M., Español T., Ehl S., Gennery A.R., Abinun M., Breborowicz A., Niehues T., Kilic S.S., Junker A., Turvey S.E., Plebani A., Sánchez B., Garty B.Z., Pignata C., Cancrini C., Litzman J., Sanal O., Baumann U., Bacchetta R., Hsu A.P., Davis J.N., Hammarström L., Davies E.G., Eren E., Arkwright P.D., Moilanen J.S., Viemann D., Khan S., Maródi L., Cant A.J., Freeman A.F., Puck J.M., Holland S.M., Grimbacher B. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J. Allergy Clin. Immunol. 2010, 125:424-432.
34. Wolach B., Eliakim A., Pomeranz A., Cohen A.H., Nusbacher J., Metzker A. Cyclosporin treatment of hyperimmunoglobulin E syndrome. Lancet 1996, 347:67.
35. Xie L., Hu X., Li Y., Zhang W., Chen L. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China. Clin. Dev. Immunol. 2010, 2010:289873.
36. Yahata Y., Shirakata Y., Tokumaru S., Yamasaki K., Sayama K., Hanakawa Y., Detmar M., Hashimoto K. Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation. J. Biol. Chem. 2003, 278:40026-40031.
37. Yavuz H., Chee R. A review on the vascular features of the hyperimmunoglobulin E syndrome. Clin. Exp. Immunol. 2010, 159:238-244.
38. Zhang Q., Davis J.C., Lamborn I.T., Freeman A.F., Jing H., Favreau A.J., Matthews H.F., Davis J., Turner M.L., Uzel G., Holland S.M., Su H.C. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 2009, 361:2046-2055.